Gozzelino, Raffaella||Poli, Maura||Arosio, Paolo <br/><br/>
Iron as Therapeutic Targets in Human Diseases Volume 2 

<br/><br/><br/>English[eng] 
<br/><br/><label>Subjects--Topical Terms: </label><br/>developmental||Anemia of chronic disease||neurodegeneration||supplementation||MHC||iron chelation therapy||osteoblast||serum biomarker||FeSO4||haptoglobin||prevention||brain development||pituitary||trauma||hepcidin||Alzheimer’s disease||chaotropes||social behavior||Africa||macrophage||anemia of inflammation||Tfr2||chelation||cardiomyocyte||IV iron therapy||Oxidative stress||treatment||chronic kidney disease||iron homeostasis||oxygen sensing||iron chelators||age-related macular degeneration (AMD)||pharmaceutical targets||non-transferrin-bound iron (NTBI)||iron dextran||pulmonary arterial hypertension||labile iron||low and middle income countries||ferroportin||gut microbiota||reducibility||non-HFE||oxidative stress||antitumor compound||senescence||electron transfer||nanotechnology||iron deficiency||neonatal period||heme oxygenase||hypoxia||Anemia||NCOA4||patient blood management||microbiome||anemia||iron mobilization||iron release||phlebotomy||peritoneal dialysis||Friedreich Ataxia||ferritin||CD8+ T cells||M cells||neurodegenerative disease||NaFeEDTA||vascular calcification||cinnamic acid derivatives||oral iron salts||lipid||acute lung injury||Iron-sulfur||Interleukin-6||neurodegeneration with brain iron accumulation||macrophages||erythroblastic islands||cystic fibrosis||neuroimmune responses||flavin nucleotide||hemopexin||Iron chelators||nutrient iron||developing countries||hereditary hypoferritinemia||iron||cancer||Indonesia||n/a||Hfe||HFE||chronic heart failure||iron supplementation||intestinal inflammation||TNF||chelators||hemolysis||children||pulmonary arterial smooth muscle cells||cytokines||didox||intravenous iron||T lymphocytes||colorectal cancer||infants||liver||ferritinophagy||hereditary hyperferritinemia||SCFA||rheumatoid arthritis||membrane interactions||Sucrosomial® iron||lung||Kupffer cell||iron chelation||erythrophagocytosis||acute kidney injury||neurophysiology||iron transporters||iron absorption||infection||ferroptosis||fluorescent iron chelator||neonatal||SNC||immunity||mycobacteria||non-haem iron||natural history||3-hydroxy-4-pyridinone||haem||inflammation||bone homeostasis||cardiovascular disease||heme||heme homeostasis||protein binding||brain||iron deficiency anemia||Fe2+-chelating activity||bioengineering||Mek/Erk||Bmp/Smad||iron delivery||genetic hemochromatosis||osteoclast||histidine||rhodamine||COPD||hemorrhage||antibacterial activity||bacteria||SLC40A1||transferrin receptor||drug delivery||nanocage||soybean seed ferritin||pig||iron metabolism||kidney||innate immunity||cataracts syndrome||erythropoiesis||obesity||mucosal immunity||iron overload||fluorophore||binding ability||inflammatory bowel disease (IBD)||osteoporosis||biomarker||bioavailability||adverse event profile||metabolism||iron-carbohydrate complex||kinetics||flavonoids||iron regulatory proteins||lung infection||non transferrin bound iron||central nurse macrophage||iron processing||malaria||neurodegenerative diseases||multifunctional iron chelators||retina||neuroinflammation||anti-hepcidin therapy||lung diseases||anaemia||RRM2||cognition||mitochondria||therapy||NBIA||red pulp macrophage||efficacy||hemochromatosis||tolerability||oral iron therapy||growth||venesections